Burden of vaccine-preventable diseases in adults (50+) in the United States: a retrospective claims analysis by Maximilian Hartmann, Nathalie Servotte, Emmanuel Aris, T. Mark Doherty, Ahmed Salem, Ekkehard Beck

Get full text

Workplace Vaccination Against COVID-19 and Seasonal Influenza in the United States: A Modeling-Based Estimation of the Health and Economic Benefits for Employers and Employees by Ekkehard Beck, Keya Joshi, Darshan Mehta, Stephane Lorenc, Bishoy Rizkalla, Nicolas Van de Velde

Get full text

Healthcare Resource Utilization (HCRU) and Direct Medical Costs Associated with Long COVID or Post-COVID-19 Conditions: Findings from a Literature Review by Elżbieta Łukomska, Krzysztof Kloc, Malwina Kowalska, Aleksandra Matjaszek, Keya Joshi, Stefan Scholz, Nicolas Van de Velde, Ekkehard Beck

Get full text

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France by Amy Lee, Benjamin Davido, Ekkehard Beck, Clarisse Demont, Keya Joshi, Michele Kohli, Michael Maschio, Mathieu Uhart, Nadia El Mouaddin

Get full text

Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States by Keya Joshi, Mariia Dronova, Ewelina Paterak, Van H. Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, Ekkehard Beck

Get full text

Estimating the Public Health and Economic Impact of Annual mRNA COVID-19 Vaccination for Adults Aged 50 and Older in South Korea’s Endemic Era by Jaehee Jung, Dain Lee, Hee-Do Yang, Ah-Young Kim, Haeun Lee, Minkyoung Kang, Ekkehard Beck, Keya Joshi, Youngju Kang, Hye-Young Kang

Get full text

Cost–benefit analysis of the National Immunization Program in Spain by Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz

Get full text